53204 Federal Register / Vol. 77, No. 170 / Friday, August 31, 2012 / Notices 

Dated: August 28, 2012. 

Martique Jones, 

Director, Regulations Development Group, 

Division B, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2012–21593 Filed 8–30–12; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3274–N] 

Medicare Program; Meeting of the 

Medicare Evidence Development and 

Coverage Advisory Committee— 

November 14, 2012 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces that a 

public meeting of the Medicare 

Evidence Development & Coverage 

Advisory Committee (MEDCAC) 

(‘‘Committee’’) will be held on 

Wednesday, November 14, 2012. The 

Committee generally provides advice 

and recommendations concerning the 

adequacy of scientific evidence needed 

to determine whether certain medical 

items and services can be covered under 

the Medicare statute. This meeting will 

focus on the use of ventricular assist 

devices (VADs), a clinical strategy for 

the management of heart failure. This 

meeting is open to the public in 

accordance with the Federal Advisory 

Committee Act (5 U.S.C. App. 2, section 

10(a)). 

DATES: Meeting Date: The public 

meeting will be held on Wednesday, 

November 14, 2012 from 7:30 a.m. until 

4:30 p.m., Eastern Standard Time (EST). 

Deadline for Submission of Written 

Comments: Written comments must be 

received at the address specified in the 

ADDRESSES section of this notice by 5 

p.m., Eastern Daylight Time (EDT), 

Monday, October 15, 2012. Once 

submitted, all comments are final. 

Deadlines for Speaker Registration 

and Presentation Materials: The 

deadline to register to be a speaker and 

to submit PowerPoint presentation 

materials and writings that will be used 

in support of an oral presentation is 5:00 

p.m., EDT on Monday, October 15, 

2012. Speakers may register by phone or 

via email by contacting the person listed 

in the FOR FURTHER INFORMATION

CONTACT section of this notice. 

Presentation materials must be received 

at the address specified in the 

ADDRESSES section of this notice. 

Deadline for All Other Attendees 

Registration: Individuals may register 

online at http://www.cms.gov/apps/

events/upcomingevents.

asp?strOrderBy=1&type=3 or by phone 

by contacting the person listed in the 

FOR FURTHER INFORMATION CONTACT

section of this notice by 5 p.m. EST, 

Wednesday, November 7, 2012. We will 

be broadcasting the meeting live via 

Webcast at http://www.cms.gov/live/. 

Deadline for Submitting a Request for 

Special Accommodations: Persons 

attending the meeting who are hearing 

or visually impaired, or have a 

condition that requires special 

assistance or accommodations, are 

asked to contact the Executive Secretary 

as specified in the FOR FURTHER

INFORMATION CONTACT section of this 

notice no later than 5:00 p.m., EDT 

Friday, November 2, 2012. 

ADDRESSES: Meeting Location: The 

meeting will be held in the main 

auditorium of the Centers for Medicare 

& Medicaid Services, 7500 Security 

Boulevard, Baltimore, MD 21244. 

Submission of Presentations and 

Comments: Presentation materials and 

written comments that will be presented 

at the meeting must be submitted via 

email to MedCACpresentations@cms.

hhs.gov or by regular mail to the contact 

listed in the FOR FURTHER INFORMATION

CONTACT section of this notice by the 

date specified in the DATES section of 

this notice. 

FOR FURTHER INFORMATION CONTACT: 

Maria Ellis, Executive Secretary for 

MEDCAC, Centers for Medicare & 

Medicaid Services, Center for Clinical 

Standards and Quality, Coverage and 

Analysis Group, S3–02–01, 7500 

Security Boulevard, Baltimore, MD 

21244 or contact Ms. Ellis by phone 

(410–786–0309) or via email at Maria.

Ellis@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

MEDCAC, formerly known as the 

Medicare Coverage Advisory Committee 

(MCAC), provides advice and 

recommendations to CMS regarding 

clinical issues. (For more information 

on MCAC, see the December 14, 1998 

Federal Register (63 FR 68780). This 

notice announces the Wednesday, 

November 14, 2012, public meeting of 

the Committee. During this meeting, the 

Committee will discuss the use of 

VADs, a clinical strategy for the 

management of heart failure. 

Background information about this 

topic, including panel materials, is 

available at http://www.cms.gov/

medicare-coverage-database/indexes/

medcac-meetings-index.aspx?bc=

BAAAAAAAAAAA&. CMS will no 

longer be providing paper copies of the 

handouts for the meeting. Electronic 

copies of all the meeting materials will 

be on the CMS Web site no later than 

2 business days before the meeting. We 

encourage the participation of 

appropriate organizations with expertise 

in the use of VADs. 

II. Meeting Format 

This meeting is open to the public. 

The Committee will hear oral 

presentations from the public for 

approximately 45 minutes. Time 

allotted for each presentation may be 

limited. If the number of registrants 

requesting to speak is greater than can 

be reasonably accommodated during the 

scheduled open public hearing session, 

CMS may conduct a lottery to determine 

the speakers for the scheduled open 

public hearing session. The contact 

person will notify interested persons 

regarding their request to speak by 

October 22, 2012. Your comments 

should focus on issues specific to the 

list of topics that we have proposed to 

the Committee. The list of research 

topics to be discussed at the meeting 

will be available on the following web 

site prior to the meeting: http://www.

cms.gov/medicare-coverage-database/

indexes/medcac-meetings-index.

aspx?bc=BAAAAAAAAAAA&. We 

require that you declare at the meeting 

whether you have any financial 

involvement with manufacturers (or 

their competitors) of any items or 

services being discussed. 

The Committee will deliberate openly 

on the topics under consideration. 

Interested persons may observe the 

deliberations, but the Committee will 

not hear further comments during this 

time except at the request of the 

chairperson. The Committee will also 

allow a 15-minute unscheduled open 

public session for any attendee to 

address issues specific to the topics 

under consideration. At the conclusion 

of the day, the members will vote and 

the Committee will make its 

recommendation(s) to CMS. 

III. Registration Instructions 

CMS’ Coverage and Analysis Group is 

coordinating meeting registration. While 

there is no registration fee, individuals 

must register to attend. You may register 

online at http://www.cms.gov/apps/ 

events/upcomingevents.asp?strOrderBy

=1&type=3 or by phone by contacting 

the person listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice by the deadline listed in the 

DATES section of this notice. Please 

provide your full name (as it appears on 

your state-issued driver’s license), 


EMCDONALD on DSK67QTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 170 / Friday, August 31, 2012 / Notices 53205 

address, organization, telephone, fax 

number(s), and email address. You will 

receive a registration confirmation with 

instructions for your arrival at the CMS 

complex or you will be notified that the 

seating capacity has been reached. 

IV. Security, Building, and Parking 

Guidelines 

This meeting will be held in a Federal 

government building; therefore, Federal 

security measures are applicable. We 

recommend that confirmed registrants 

arrive reasonably early, but no earlier 

than 45 minutes prior to the start of the 

meeting, to allow additional time to 

clear security. Security measures 

include the following: 

• Presentation of government-issued 

photographic identification to the 

Federal Protective Service or Guard 

Service personnel. 

• Inspection of vehicle’s interior and 

exterior (this includes engine and trunk 

inspection) at the entrance to the 

grounds. Parking permits and 

instructions will be issued after the 

vehicle inspection. 

• Inspection, via metal detector or 

other applicable means of all persons 

brought entering the building. We note 

that all items brought into CMS, 

whether personal or for the purpose of 

presentation or to support a 

presentation, are subject to inspection. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for 

presentation or to support a 

presentation. 

Note: Individuals who are not 

registered in advance will not be 

permitted to enter the building and will 

be unable to attend the meeting. The 

public may not enter the building earlier 

than 45 minutes prior to the convening 

of the meeting. All visitors must be 

escorted in areas other than the lower 

and first floor levels in the Central 

Building. 

Authority: 5 U.S.C. App. 2, section 10(a). 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare—Hospital 

Insurance; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: August 23, 2012. 

Patrick Conway, 

CMS Chief Medical Officer and Director, 

Center for Clinical Standards and Quality, 

Centers for Medicare & Medicaid Services. 

[FR Doc. 2012–21583 Filed 8–30–12; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Eukaryotic Parasite Vector Biology. 

Date: September 20–21, 2012. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Fouad A El-Zaatari, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3206, 

MSC 7808, Bethesda, MD 20814–9692, (301) 

435–1149, elzaataf@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group, 

Behavioral Medicine, Interventions and 

Outcomes Study Section. 

Date: October 4–5, 2012. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin Riverwalk, 420 W 

Market Street, San Antonio, TX 78205. 

Contact Person: Lee S Mann, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7848, Bethesda, MD 20892, 301–435– 

0677, mannl@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group, 

Social Psychology, Personality and 

Interpersonal Processes Study Section. 

Date: October 4–5, 2012. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Marriott, 1221 22nd 

Street NW., Washington, DC 20037. 

Contact Person: Monica Basco, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3220, 

MSC 7808, Bethesda, MD 20892, 301–496– 

7010, bascoma@mail.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group, 

Vascular Cell and Molecular Biology Study 

Section. 

Date: October 4–5, 2012. 

Time: 8:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn—Bethesda 

Downtown, 7355 Wisconsin Ave, Bethesda, 

MD 20814. 

Contact Person: Larry Pinkus, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4132, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1214, pinkusl@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group, Cellular 

Mechanisms in Aging and Development 

Study Section. 

Date: October 4–5, 2012. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street 

NW., Washington, DC 20036. 

Contact Person: John Burch, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 3213, 

MSC 7808, Bethesda, MD 20892, 301–408– 

9519, burchjb@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group, 

Psychosocial Development, Risk and 

Prevention Study Section. 

Date: October 4–5, 2012. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Marriott, 1221 22nd 

Street NW., Washington, DC 20037. 

Contact Person: Anna L Riley, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7759, Bethesda, MD 20892, 301–435– 

2889, rileyann@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group, 

Host Interactions with Bacterial Pathogens 

Study Section. 

Date: October 4, 2012. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: Crowne Plaza Hotel—Silver Spring, 

8777 Georgia Avenue, Silver Spring, MD 

20910. 

Contact Person: Fouad A El-Zaatari, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

1149, elzaataf@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Biophysics of Neural Systems 

Study Section. 

Date: October 4, 2012. 

Time: 8:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Harborplace Hotel, 202 

East Pratt Street, Baltimore, MD 21202. 


EMCDONALD on DSK67QTVN1PROD with NOTICES